What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q1 2021?

130 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 67,671,701
Share change: +1,114,702
Total reported value: $311,885,548
Put/Call ratio: 48%
Price per share: $4.61
Number of holders: 130
Value change: +$10,809,324
Number of buys: 64
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 14888U101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	13F	Company	8.1%	10,000,000	$33,400,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	6.3%	7,744,197	$25,866,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	5%	6,113,930	$20,421,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	4.7%	5,771,079	$19,275,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.6%	3,222,590	$10,763,000	—	31 Dec 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	2.2%	2,671,337	$8,921,000	—	31 Dec 2020	13F
ROYCE & ASSOCIATES LP	13F	Company	2%	2,405,129	$8,033,000	—	31 Dec 2020	13F
Atle Fund Management AB	13F	Company	1.4%	1,750,000	$5,845,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	1,602,694	$5,352,000	—	31 Dec 2020	13F
LSV ASSET MANAGEMENT	13F	Company	1.2%	1,493,137	$4,987,000	—	31 Dec 2020	13F
AIGH Capital Management LLC	13F	Company	1.1%	1,350,554	$4,511,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	1%	1,252,341	$4,184,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.81%	994,740	$3,323,000	—	31 Dec 2020	13F
Man Group plc	13F	Company	0.81%	993,562	$3,318,000	—	31 Dec 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.81%	993,431	$3,318,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.74%	916,829	$3,063,000	—	31 Dec 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.74%	912,527	$3,048,000	—	31 Dec 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.6%	734,029	$2,452,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.59%	728,392	$2,433,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.56%	685,761	$2,291,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.53%	647,046	$2,161,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.51%	631,851	$2,111,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.51%	626,022	$2,091,000	—	31 Dec 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.36%	445,720	$1,487,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.35%	437,086	$1,460,000	—	31 Dec 2020	13F
GABLES CAPITAL MANAGEMENT INC.	13F	Company	0.34%	413,364	$1,381,000	—	31 Dec 2020	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.31%	376,207	$1,257,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.3%	369,071	$1,233,000	—	31 Dec 2020	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.29%	362,065	$1,209,000	—	31 Dec 2020	13F
Brandywine Global Investment Management, LLC	13F	Company	0.29%	357,325	$1,193,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.29%	356,947	$1,192,000	—	31 Dec 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.28%	340,114	$1,173,000	—	31 Dec 2020	13F
Worth Venture Partners, LLC	13F	Company	0.28%	344,702	$1,151,000	—	31 Dec 2020	13F
Wealthspire Advisors, LLC	13F	Company	0.27%	337,770	$1,128,000	—	31 Dec 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.27%	337,214	$1,126,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0.27%	329,591	$1,101,000	—	31 Dec 2020	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.24%	295,292	$986,000	—	31 Dec 2020	13F
ALPS ADVISORS INC	13F	Company	0.22%	265,002	$885,000	—	31 Dec 2020	13F
BARCLAYS PLC	13F	Company	0.21%	254,488	$849,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.2%	241,173	$806,000	—	31 Dec 2020	13F
HANCOCK WHITNEY CORP	13F	Company	0.19%	239,292	$799,000	—	31 Dec 2020	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.19%	236,911	$791,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.19%	236,410	$790,000	—	31 Dec 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	0.19%	233,210	$779,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.18%	225,280	$752,000	—	31 Dec 2020	13F
TANAKA CAPITAL MANAGEMENT INC	13F	Company	0.18%	225,274	$752,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.18%	219,300	$732,000	—	31 Dec 2020	13F
Prairiewood Capital, LLC	13F	Company	0.17%	213,432	$713,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.16%	195,001	$651,303	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.16%	193,455	$646,000	—	31 Dec 2020	13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q1 2021

As of 31 Mar 2021, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,671,701 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, PRUDENTIAL FINANCIAL INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, LSV ASSET MANAGEMENT, and ACADIAN ASSET MANAGEMENT LLC. This page lists 130 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

131

Q1 2021 holders

130

Holder diff

-1

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.